Core Insights - Canadian National Railway Company (CNI) reported second-quarter 2025 results with earnings and revenues falling short of Zacks Consensus Estimate, leading to a 4.9% decline in stock price since the earnings release on July 22 [1] Financial Performance - Earnings per share (EPS) were $1.35 (C$1.87), missing the Zacks Consensus Estimate of $1.37 and remaining flat year-over-year [3] - Revenues for Q2 2025 were $3.09 billion (C$4.3 billion), below the Zacks Consensus Estimate of $3.16 billion, and declined 2.4% year-over-year [3] - Revenue ton-miles (RTMs) decreased by 1% year-over-year, while carloads dropped by 0.4% [4] - Operating expenses fell by 5.2% year-over-year due to cost-cutting measures [4] - Operating income grew by 4.9% compared to Q2 2024, with the operating ratio improving by 0.5 points to 61.7% [5] Segment Performance - Freight revenues, which accounted for 95.7% of total revenues, decreased by 1.5% year-over-year [6] - Specific declines in freight revenues included petroleum and chemicals (-5%), metals and minerals (-7%), forest products (-8%), intermodal (-3%), and automotive (-6%) [6] - Revenues from grain and fertilizers increased by 13% year-over-year, while coal revenues remained flat [6][7] Liquidity and Capital Management - CNI ended Q1 2025 with cash and cash equivalents of C$216 million, down from C$389 million at the end of Q4 2024 [9] - Long-term debt decreased to C$19.3 billion from C$19.7 billion at the end of December 2024 [9] - CNI generated C$1.75 billion from operating activities, with free cash flow at C$922 million [9] - Under its current Normal Course Issuer Bid (NCIB), CNI may repurchase up to 20 million common shares, having repurchased 2.2 million shares for $300 million as of March 31, 2025 [10] Outlook - For full-year 2025, CNI anticipates mid to high-single-digit adjusted EPS growth, revised down from a previous guidance of 10%-15% [11] - CNI plans to invest approximately C$3.4 billion in its capital program, net of customer reimbursements [11] - The company has withdrawn its financial outlook for the 2024-2026 period due to macroeconomic uncertainty [11]

Core Insights - Invesco reported $1.1 billion in revenue for Q2 2025, a year-over-year increase of 1.7%, but the EPS decreased to $0.36 from $0.43 a year ago, indicating a decline in profitability [1] - The revenue fell short of the Zacks Consensus Estimate by -0.54%, and the EPS was -12.2% below the consensus estimate [1] Financial Performance Metrics - Invesco's shares have returned +35.3% over the past month, significantly outperforming the Zacks S&P 500 composite's +5.9% change, and the stock holds a Zacks Rank 1 (Strong Buy) [3] - Assets Under Management (AUM) for ETFs and Index reached $546.90 billion, exceeding the average estimate of $512.82 billion [4] - Total average AUM was reported at $1,897.40 billion, higher than the estimated $1,855.71 billion [4] - AUM for Fundamental Fixed Income was $301.60 billion, surpassing the estimate of $297.02 billion [4] - AUM for Private Markets was $131.20 billion, above the average estimate of $129.82 billion [4] - AUM for China JV & India was $120.20 billion, compared to the estimate of $114.48 billion [4] - AUM for Multi-Asset/Other was $64.10 billion, exceeding the estimate of $60.48 billion [4] - AUM for Global Liquidity was $196.40 billion, slightly below the estimate of $197.85 billion [4] - AUM for QQQs was $352.70 billion, significantly higher than the estimate of $314.54 billion [4] - Average AUM for ETFs & Index was $509.70 billion, above the estimate of $501.91 billion [4] Revenue Breakdown - Operating revenues from Other revenues were $48.2 million, below the estimate of $53.25 million, but showed a +2.1% year-over-year change [4] - Service and distribution fees generated $363.8 million, lower than the estimated $375.77 million, with a year-over-year change of +0.6% [4] - Performance fees were reported at $2.6 million, significantly below the average estimate of $8.99 million, reflecting a -70.1% year-over-year decline [4]

Financial Data and Key Metrics Changes - For the full year 2024, same store net operating revenues increased by 5.5% and adjusted EBITDA improved by 6% [9][17] - Adjusted EBITDA for the fourth quarter was $428 million, compared to $386 million in the prior year period, with a margin of 13.1%, up from 12.1% [16][17] - Cash flows from operations were $216 million for the fourth quarter, up from $90 million in the fourth quarter of 2023, and $480 million for the full year of 2024, consistent with guidance [19][20] Business Line Data and Key Metrics Changes - Same store admissions increased by 3.2%, adjusted admissions by 2.7%, and surgeries by 1.3% for the full year 2024 [7] - Same store emergency department visits were up 1% and surgeries were up 0.9% in the fourth quarter [16] - Same store ambulatory surgery center cases increased by 14% last year [8] Market Data and Key Metrics Changes - The company completed divestitures in Cleveland, Tennessee, and Statesboro, North Carolina, with plans for additional divestitures expected to generate over $1 billion in total proceeds [10][22] - The net debt to trailing adjusted EBITDA improved to 7.4 times, down from 7.9 times at the end of 2023 [22] Company Strategy and Development Direction - The company is focused on expanding outpatient access, including primary care, specialty practices, and urgent care centers, with significant capital investments [7][15] - The implementation of a new ERP system is expected to drive efficiencies and reduce costs, with estimated savings of $40 million to $60 million in 2025 [23] - The company anticipates further expansion of internally managed hospital-based provider services in 2025 [12] Management's Comments on Operating Environment and Future Outlook - Management noted stabilization in payer downgrades and denials, which had been a troubling trend for healthcare providers [11][17] - The company expects organic growth of $75 million to $100 million in 2025, with net revenue guidance of $12.2 billion to $12.6 billion [23] - Management expressed confidence in the approval of directed payment programs in New Mexico and Tennessee, which could add an incremental $100 million to $125 million to annual EBITDA [24][50] Other Important Information - The company experienced a $10 million impact from a hurricane in Q4, with one hospital still shut down as a result [74] - The company is in discussions for additional strategic divestitures expected to be announced soon [22] Q&A Session Summary Question: Can you help bridge 2024 to 2025 guidance? - Management provided a high-level bridge starting with 2024 EBITDA of $1.54 billion, accounting for reductions from divestitures and adding organic growth to reach the midpoint of 2025 guidance [27][28] Question: What are the strategic moves expected moving forward? - Management highlighted ongoing investments in core portfolio growth, including outpatient and procedural capacity expansions, and noted that there are still investable opportunities in the pipeline [30][33] Question: Can you quantify the continued hurricane impact in Q4? - The hurricane impact was as expected at $10 million, with one hospital shut down for the entire quarter [74]